Sangamo Therapeutics Presents Latest Advances In Zinc Finger Nuclease Platform Technology At Keysto | SGMO Message Board Posts

Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  84609 of 87438  at  1/11/2017 10:11:52 AM  by

bin2gray


 In response to msg 84589 by  bct1192
view thread

Re: Sangamo Therapeutics Presents Latest Advances In Zinc Finger Nuclease Platform Technology At Keystone Symposium On Precision Genome Engineering

"That's it, in a nut shell. Are ZFNs perfect? No. I bet you were under the impression that that mattered. It doesn't."

I've said this very thing here in the past in the context of discussing BLUE who has a tremendous off-target issue, but also that the fact that it (apparently) does not matter much applies to CRISPR too.

I have no problem with what you say in this post, but unless you have almost everybody on the board blocked or you don't read it regularly I find it difficult to believe that you don't conclude that most here do think just like the OP I responded to.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 279
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2016 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.

Loading...